The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study

Table 3 Sub-group analysis, recency of exposure

	Overall NPEs		Sleep disorder		Mood disorder		Anxiety disorder
	OR	CI	OR	CI	OR	CI	OR	CI
Group 1 (0–60 days)
Crude OR	1.88	1.72–2.07	1.80	1.58–2.05	1.81	1.57–2.08	1.92	1.68–2.19
Adjusted^a OR	1.99	1.81–2.18	1.85	1.62–2.11	2.00	1.73–2.30	2.05	1.79–2.35
Group 2 (61–120 days)
Crude OR	1.54	1.34–1.76	1.43	1.18–1.73	1.40	1.14–1.72	1.43	1.18–1.73
Adjusted^a OR	1.63	1.42–1.86	1.47	1.21–1.79	1.55	1.26–1.91	1.53	1.26–1.85
Group 3 (> 120 days)
Crude OR	1.38	1.27–1.50	1.30	1.15–1.47	1.30	1.15–1.48	1.30	1.16–1.47
Adjusted^a OR	1.46	1.34–1.59	1.34	1.18–1.51	1.44	1.27–1.64	1.38	1.23–1.56

Abbreviations: NPE Neuropsychiatric Event, OR Odd Ratio, CI Confidence Interval
^a Adjusted by baseline characteristics in Table 2. Logistic regression was used in this analysis. All analyses have p value under 0.05

ISSN: 2054-7064